WEBVTT
Kind: captions
Language: en

00:00:03.440 --> 00:00:06.019 align:start position:0%
 
alopecia<00:00:04.440><c> areata</c><00:00:04.710><c> is</c><00:00:05.009><c> an</c><00:00:05.160><c> autoimmune</c><00:00:05.400><c> form</c><00:00:05.879><c> of</c>

00:00:06.019 --> 00:00:06.029 align:start position:0%
alopecia areata is an autoimmune form of
 

00:00:06.029 --> 00:00:08.450 align:start position:0%
alopecia areata is an autoimmune form of
hair<00:00:06.210><c> loss</c><00:00:06.240><c> where</c><00:00:06.750><c> T</c><00:00:07.470><c> cells</c><00:00:07.710><c> attack</c><00:00:08.160><c> the</c>

00:00:08.450 --> 00:00:08.460 align:start position:0%
hair loss where T cells attack the
 

00:00:08.460 --> 00:00:10.400 align:start position:0%
hair loss where T cells attack the
growing<00:00:08.760><c> hair</c><00:00:08.940><c> follicle</c><00:00:09.389><c> it</c><00:00:09.719><c> is</c><00:00:09.900><c> not</c><00:00:10.170><c> a</c>

00:00:10.400 --> 00:00:10.410 align:start position:0%
growing hair follicle it is not a
 

00:00:10.410 --> 00:00:12.770 align:start position:0%
growing hair follicle it is not a
life-threatening<00:00:11.040><c> form</c><00:00:11.730><c> of</c><00:00:12.090><c> autoimmunity</c>

00:00:12.770 --> 00:00:12.780 align:start position:0%
life-threatening form of autoimmunity
 

00:00:12.780 --> 00:00:15.259 align:start position:0%
life-threatening form of autoimmunity
however<00:00:13.349><c> it</c><00:00:13.500><c> is</c><00:00:13.620><c> a</c><00:00:13.769><c> life</c><00:00:13.980><c> altering</c><00:00:14.400><c> form</c><00:00:14.940><c> of</c>

00:00:15.259 --> 00:00:15.269 align:start position:0%
however it is a life altering form of
 

00:00:15.269 --> 00:00:16.250 align:start position:0%
however it is a life altering form of
autoimmune<00:00:15.750><c> disease</c>

00:00:16.250 --> 00:00:16.260 align:start position:0%
autoimmune disease
 

00:00:16.260 --> 00:00:19.010 align:start position:0%
autoimmune disease
it<00:00:17.130><c> affects</c><00:00:17.490><c> patients</c><00:00:18.090><c> in</c><00:00:18.210><c> a</c><00:00:18.300><c> very</c><00:00:18.570><c> profound</c>

00:00:19.010 --> 00:00:19.020 align:start position:0%
it affects patients in a very profound
 

00:00:19.020 --> 00:00:21.560 align:start position:0%
it affects patients in a very profound
and<00:00:19.170><c> very</c><00:00:19.320><c> personal</c><00:00:19.890><c> way</c><00:00:20.369><c> to</c><00:00:20.789><c> undergo</c><00:00:21.270><c> hair</c>

00:00:21.560 --> 00:00:21.570 align:start position:0%
and very personal way to undergo hair
 

00:00:21.570 --> 00:00:23.540 align:start position:0%
and very personal way to undergo hair
loss<00:00:21.750><c> I</c><00:00:22.020><c> could</c><00:00:22.529><c> say</c><00:00:22.680><c> that</c><00:00:22.890><c> with</c><00:00:23.039><c> authority</c>

00:00:23.540 --> 00:00:23.550 align:start position:0%
loss I could say that with authority
 

00:00:23.550 --> 00:00:25.220 align:start position:0%
loss I could say that with authority
because<00:00:23.580><c> I'm</c><00:00:24.000><c> one</c><00:00:24.180><c> of</c><00:00:24.300><c> them</c><00:00:24.420><c> so</c><00:00:24.660><c> the</c><00:00:24.810><c> reason</c><00:00:25.109><c> my</c>

00:00:25.220 --> 00:00:25.230 align:start position:0%
because I'm one of them so the reason my
 

00:00:25.230 --> 00:00:27.140 align:start position:0%
because I'm one of them so the reason my
lab<00:00:25.410><c> studies</c><00:00:25.560><c> this</c><00:00:25.920><c> is</c><00:00:25.980><c> because</c><00:00:26.460><c> I</c><00:00:26.849><c> actually</c>

00:00:27.140 --> 00:00:27.150 align:start position:0%
lab studies this is because I actually
 

00:00:27.150 --> 00:00:29.060 align:start position:0%
lab studies this is because I actually
have<00:00:27.510><c> alopecia</c><00:00:27.869><c> areata</c><00:00:28.170><c> and</c><00:00:28.500><c> that's</c><00:00:28.920><c> what</c>

00:00:29.060 --> 00:00:29.070 align:start position:0%
have alopecia areata and that's what
 

00:00:29.070 --> 00:00:30.800 align:start position:0%
have alopecia areata and that's what
really<00:00:29.189><c> sparked</c><00:00:29.580><c> us</c><00:00:29.760><c> to</c><00:00:30.330><c> do</c><00:00:30.449><c> this</c><00:00:30.570><c> type</c><00:00:30.779><c> of</c>

00:00:30.800 --> 00:00:30.810 align:start position:0%
really sparked us to do this type of
 

00:00:30.810 --> 00:00:33.110 align:start position:0%
really sparked us to do this type of
work<00:00:31.140><c> over</c><00:00:31.800><c> 6</c><00:00:32.040><c> million</c><00:00:32.250><c> people</c><00:00:32.460><c> in</c><00:00:32.730><c> the</c><00:00:32.820><c> u.s.</c>

00:00:33.110 --> 00:00:33.120 align:start position:0%
work over 6 million people in the u.s.
 

00:00:33.120 --> 00:00:35.000 align:start position:0%
work over 6 million people in the u.s.
also<00:00:33.360><c> suffer</c><00:00:33.899><c> from</c><00:00:33.930><c> various</c><00:00:34.530><c> forms</c><00:00:34.890><c> of</c>

00:00:35.000 --> 00:00:35.010 align:start position:0%
also suffer from various forms of
 

00:00:35.010 --> 00:00:36.350 align:start position:0%
also suffer from various forms of
alopecia<00:00:35.219><c> areata</c><00:00:35.610><c> so</c><00:00:35.969><c> this</c><00:00:36.180><c> is</c><00:00:36.329><c> a</c>

00:00:36.350 --> 00:00:36.360 align:start position:0%
alopecia areata so this is a
 

00:00:36.360 --> 00:00:38.540 align:start position:0%
alopecia areata so this is a
tremendously<00:00:36.960><c> large</c><00:00:37.680><c> and</c><00:00:38.070><c> motivated</c>

00:00:38.540 --> 00:00:38.550 align:start position:0%
tremendously large and motivated
 

00:00:38.550 --> 00:00:40.250 align:start position:0%
tremendously large and motivated
population<00:00:39.120><c> of</c><00:00:39.210><c> patients</c><00:00:39.360><c> who</c><00:00:39.690><c> have</c><00:00:39.870><c> no</c><00:00:40.050><c> other</c>

00:00:40.250 --> 00:00:40.260 align:start position:0%
population of patients who have no other
 

00:00:40.260 --> 00:00:42.020 align:start position:0%
population of patients who have no other
treatments<00:00:40.770><c> available</c><00:00:41.250><c> treatment</c><00:00:41.820><c> for</c><00:00:41.969><c> this</c>

00:00:42.020 --> 00:00:42.030 align:start position:0%
treatments available treatment for this
 

00:00:42.030 --> 00:00:43.970 align:start position:0%
treatments available treatment for this
disease<00:00:42.360><c> in</c><00:00:42.660><c> the</c><00:00:42.750><c> past</c><00:00:42.989><c> has</c><00:00:43.290><c> been</c><00:00:43.320><c> hit</c><00:00:43.680><c> miss</c>

00:00:43.970 --> 00:00:43.980 align:start position:0%
disease in the past has been hit miss
 

00:00:43.980 --> 00:00:47.240 align:start position:0%
disease in the past has been hit miss
with<00:00:44.340><c> steroids</c><00:00:44.910><c> and</c><00:00:45.360><c> with</c><00:00:46.320><c> varying</c><00:00:47.100><c> degrees</c>

00:00:47.240 --> 00:00:47.250 align:start position:0%
with steroids and with varying degrees
 

00:00:47.250 --> 00:00:48.190 align:start position:0%
with steroids and with varying degrees
of<00:00:47.489><c> success</c>

00:00:48.190 --> 00:00:48.200 align:start position:0%
of success
 

00:00:48.200 --> 00:00:51.080 align:start position:0%
of success
we've<00:00:49.200><c> been</c><00:00:49.379><c> excited</c><00:00:49.860><c> to</c><00:00:50.010><c> see</c><00:00:50.190><c> data</c><00:00:50.610><c> both</c><00:00:50.879><c> in</c>

00:00:51.080 --> 00:00:51.090 align:start position:0%
we've been excited to see data both in
 

00:00:51.090 --> 00:00:53.420 align:start position:0%
we've been excited to see data both in
mice<00:00:51.329><c> and</c><00:00:51.570><c> now</c><00:00:51.660><c> in</c><00:00:51.809><c> people</c><00:00:52.170><c> to</c><00:00:52.739><c> show</c><00:00:52.949><c> that</c><00:00:53.160><c> we</c>

00:00:53.420 --> 00:00:53.430 align:start position:0%
mice and now in people to show that we
 

00:00:53.430 --> 00:00:55.790 align:start position:0%
mice and now in people to show that we
can<00:00:53.699><c> reverse</c><00:00:54.120><c> this</c><00:00:54.420><c> disease</c><00:00:54.780><c> with</c><00:00:55.469><c> small</c>

00:00:55.790 --> 00:00:55.800 align:start position:0%
can reverse this disease with small
 

00:00:55.800 --> 00:00:58.430 align:start position:0%
can reverse this disease with small
molecules<00:00:56.399><c> that</c><00:00:56.699><c> are</c><00:00:56.879><c> aimed</c><00:00:57.629><c> at</c><00:00:57.899><c> reversing</c>

00:00:58.430 --> 00:00:58.440 align:start position:0%
molecules that are aimed at reversing
 

00:00:58.440 --> 00:01:01.220 align:start position:0%
molecules that are aimed at reversing
the<00:00:58.770><c> inflammatory</c><00:00:58.980><c> condition</c><00:00:59.850><c> in</c><00:01:00.000><c> humans</c><00:01:00.600><c> the</c>

00:01:01.220 --> 00:01:01.230 align:start position:0%
the inflammatory condition in humans the
 

00:01:01.230 --> 00:01:03.290 align:start position:0%
the inflammatory condition in humans the
trough<00:01:01.500><c> reversal</c><00:01:02.039><c> in</c><00:01:02.219><c> the</c><00:01:02.879><c> treatment</c><00:01:03.120><c> of</c>

00:01:03.290 --> 00:01:03.300 align:start position:0%
trough reversal in the treatment of
 

00:01:03.300 --> 00:01:06.320 align:start position:0%
trough reversal in the treatment of
alopecia<00:01:03.510><c> areata</c><00:01:04.049><c> got</c><00:01:04.979><c> started</c><00:01:05.489><c> based</c><00:01:05.790><c> on</c><00:01:06.119><c> the</c>

00:01:06.320 --> 00:01:06.330 align:start position:0%
alopecia areata got started based on the
 

00:01:06.330 --> 00:01:08.810 align:start position:0%
alopecia areata got started based on the
clinical<00:01:06.810><c> a</c><00:01:07.320><c> genetic</c><00:01:07.920><c> and</c><00:01:08.159><c> immunologic</c>

00:01:08.810 --> 00:01:08.820 align:start position:0%
clinical a genetic and immunologic
 

00:01:08.820 --> 00:01:11.359 align:start position:0%
clinical a genetic and immunologic
discoveries<00:01:09.630><c> made</c><00:01:09.930><c> by</c><00:01:09.960><c> doctors</c><00:01:10.740><c> Christiano</c>

00:01:11.359 --> 00:01:11.369 align:start position:0%
discoveries made by doctors Christiano
 

00:01:11.369 --> 00:01:12.429 align:start position:0%
discoveries made by doctors Christiano
and<00:01:11.610><c> Klein's</c>

00:01:12.429 --> 00:01:12.439 align:start position:0%
and Klein's
 

00:01:12.439 --> 00:01:14.929 align:start position:0%
and Klein's
in<00:01:13.439><c> investigating</c><00:01:14.280><c> the</c><00:01:14.400><c> genetics</c><00:01:14.820><c> of</c>

00:01:14.929 --> 00:01:14.939 align:start position:0%
in investigating the genetics of
 

00:01:14.939 --> 00:01:17.240 align:start position:0%
in investigating the genetics of
alopecia<00:01:15.150><c> areata</c><00:01:15.659><c> they</c><00:01:16.020><c> were</c><00:01:16.170><c> able</c><00:01:16.439><c> to</c><00:01:16.470><c> then</c>

00:01:17.240 --> 00:01:17.250 align:start position:0%
alopecia areata they were able to then
 

00:01:17.250 --> 00:01:19.550 align:start position:0%
alopecia areata they were able to then
subsequently<00:01:17.939><c> pinpoint</c><00:01:18.479><c> to</c><00:01:18.750><c> several</c><00:01:19.140><c> immune</c>

00:01:19.550 --> 00:01:19.560 align:start position:0%
subsequently pinpoint to several immune
 

00:01:19.560 --> 00:01:21.410 align:start position:0%
subsequently pinpoint to several immune
pathways<00:01:19.740><c> that</c><00:01:20.250><c> appear</c><00:01:20.490><c> to</c><00:01:20.520><c> be</c><00:01:20.729><c> important</c><00:01:21.240><c> in</c>

00:01:21.410 --> 00:01:21.420 align:start position:0%
pathways that appear to be important in
 

00:01:21.420 --> 00:01:23.690 align:start position:0%
pathways that appear to be important in
alopecia<00:01:21.780><c> areata</c><00:01:22.170><c> the</c><00:01:23.070><c> next</c><00:01:23.369><c> step</c><00:01:23.520><c> was</c>

00:01:23.690 --> 00:01:23.700 align:start position:0%
alopecia areata the next step was
 

00:01:23.700 --> 00:01:25.490 align:start position:0%
alopecia areata the next step was
identifying<00:01:24.330><c> available</c><00:01:24.900><c> drugs</c><00:01:25.200><c> that</c>

00:01:25.490 --> 00:01:25.500 align:start position:0%
identifying available drugs that
 

00:01:25.500 --> 00:01:28.070 align:start position:0%
identifying available drugs that
actually<00:01:26.009><c> inhibit</c><00:01:26.580><c> these</c><00:01:26.700><c> pathways</c><00:01:27.270><c> and</c><00:01:27.540><c> this</c>

00:01:28.070 --> 00:01:28.080 align:start position:0%
actually inhibit these pathways and this
 

00:01:28.080 --> 00:01:29.990 align:start position:0%
actually inhibit these pathways and this
is<00:01:28.229><c> the</c><00:01:28.350><c> basis</c><00:01:28.710><c> upon</c><00:01:28.740><c> which</c><00:01:29.009><c> ruxolitinib</c><00:01:29.490><c> was</c>

00:01:29.990 --> 00:01:30.000 align:start position:0%
is the basis upon which ruxolitinib was
 

00:01:30.000 --> 00:01:32.690 align:start position:0%
is the basis upon which ruxolitinib was
selected<00:01:30.590><c> once</c><00:01:31.590><c> the</c><00:01:31.710><c> drug</c><00:01:31.920><c> was</c><00:01:32.070><c> selected</c><00:01:32.549><c> we</c>

00:01:32.690 --> 00:01:32.700 align:start position:0%
selected once the drug was selected we
 

00:01:32.700 --> 00:01:36.670 align:start position:0%
selected once the drug was selected we
then<00:01:32.939><c> went</c><00:01:33.210><c> about</c><00:01:33.770><c> designing</c><00:01:34.770><c> a</c><00:01:35.460><c> trial</c><00:01:35.850><c> to</c>

00:01:36.670 --> 00:01:36.680 align:start position:0%
then went about designing a trial to
 

00:01:36.680 --> 00:01:39.469 align:start position:0%
then went about designing a trial to
preliminary<00:01:37.680><c> test</c><00:01:38.340><c> its</c><00:01:38.610><c> effect</c><00:01:38.939><c> on</c><00:01:39.030><c> alopecia</c>

00:01:39.469 --> 00:01:39.479 align:start position:0%
preliminary test its effect on alopecia
 

00:01:39.479 --> 00:01:42.679 align:start position:0%
preliminary test its effect on alopecia
areata<00:01:39.900><c> we</c><00:01:40.650><c> now</c><00:01:40.890><c> have</c><00:01:41.220><c> the</c><00:01:41.970><c> ability</c><00:01:42.060><c> to</c>

00:01:42.679 --> 00:01:42.689 align:start position:0%
areata we now have the ability to
 

00:01:42.689 --> 00:01:46.749 align:start position:0%
areata we now have the ability to
identify<00:01:43.850><c> potential</c><00:01:44.850><c> targets</c><00:01:45.420><c> for</c><00:01:46.229><c> treatment</c>

00:01:46.749 --> 00:01:46.759 align:start position:0%
identify potential targets for treatment
 

00:01:46.759 --> 00:01:51.440 align:start position:0%
identify potential targets for treatment
and<00:01:48.290><c> using</c><00:01:49.340><c> what</c><00:01:50.340><c> some</c><00:01:50.880><c> people</c><00:01:51.030><c> call</c><00:01:51.420><c> a</c>

00:01:51.440 --> 00:01:51.450 align:start position:0%
and using what some people call a
 

00:01:51.450 --> 00:01:53.630 align:start position:0%
and using what some people call a
mechanism<00:01:52.110><c> driven</c><00:01:52.619><c> approach</c><00:01:52.979><c> that</c><00:01:53.280><c> is</c><00:01:53.430><c> to</c>

00:01:53.630 --> 00:01:53.640 align:start position:0%
mechanism driven approach that is to
 

00:01:53.640 --> 00:01:57.410 align:start position:0%
mechanism driven approach that is to
look<00:01:53.850><c> for</c><00:01:54.829><c> pathways</c><00:01:55.829><c> that</c><00:01:56.340><c> are</c><00:01:56.399><c> altered</c><00:01:56.939><c> in</c>

00:01:57.410 --> 00:01:57.420 align:start position:0%
look for pathways that are altered in
 

00:01:57.420 --> 00:02:01.130 align:start position:0%
look for pathways that are altered in
human<00:01:57.990><c> disease</c><00:01:58.350><c> and</c><00:01:58.850><c> then</c><00:01:59.850><c> to</c><00:02:00.060><c> see</c><00:02:00.299><c> if</c><00:02:00.479><c> those</c>

00:02:01.130 --> 00:02:01.140 align:start position:0%
human disease and then to see if those
 

00:02:01.140 --> 00:02:04.789 align:start position:0%
human disease and then to see if those
alterations<00:02:01.740><c> lend</c><00:02:02.369><c> themselves</c><00:02:03.259><c> to</c><00:02:04.259><c> some</c><00:02:04.560><c> type</c>

00:02:04.789 --> 00:02:04.799 align:start position:0%
alterations lend themselves to some type
 

00:02:04.799 --> 00:02:07.190 align:start position:0%
alterations lend themselves to some type
of<00:02:04.829><c> manipulation</c><00:02:05.579><c> either</c><00:02:06.200><c> pharmacologically</c>

00:02:07.190 --> 00:02:07.200 align:start position:0%
of manipulation either pharmacologically
 

00:02:07.200 --> 00:02:07.710 align:start position:0%
of manipulation either pharmacologically
or<00:02:07.409><c> Jen</c>

00:02:07.710 --> 00:02:07.720 align:start position:0%
or Jen
 

00:02:07.720 --> 00:02:10.950 align:start position:0%
or Jen
to<00:02:07.870><c> clay</c><00:02:08.080><c> or</c><00:02:08.320><c> both</c><00:02:09.210><c> and</c><00:02:10.210><c> I</c><00:02:10.330><c> think</c><00:02:10.360><c> that's</c><00:02:10.750><c> what</c>

00:02:10.950 --> 00:02:10.960 align:start position:0%
to clay or both and I think that's what
 

00:02:10.960 --> 00:02:14.310 align:start position:0%
to clay or both and I think that's what
we<00:02:11.140><c> have</c><00:02:11.350><c> in</c><00:02:11.890><c> the</c><00:02:12.100><c> case</c><00:02:12.580><c> of</c><00:02:12.850><c> this</c><00:02:13.060><c> study</c><00:02:13.390><c> which</c>

00:02:14.310 --> 00:02:14.320 align:start position:0%
we have in the case of this study which
 

00:02:14.320 --> 00:02:18.390 align:start position:0%
we have in the case of this study which
is<00:02:14.730><c> an</c><00:02:15.730><c> autoimmune</c><00:02:16.150><c> disease</c><00:02:16.600><c> that</c><00:02:17.230><c> has</c><00:02:17.560><c> eluded</c>

00:02:18.390 --> 00:02:18.400 align:start position:0%
is an autoimmune disease that has eluded
 

00:02:18.400 --> 00:02:23.180 align:start position:0%
is an autoimmune disease that has eluded
for<00:02:18.940><c> decades</c><00:02:19.840><c> any</c><00:02:20.740><c> basic</c><00:02:21.310><c> understanding</c><00:02:22.240><c> of</c>

00:02:23.180 --> 00:02:23.190 align:start position:0%
for decades any basic understanding of
 

00:02:23.190 --> 00:02:27.420 align:start position:0%
for decades any basic understanding of
the<00:02:25.170><c> development</c><00:02:26.170><c> and</c><00:02:26.290><c> the</c><00:02:26.380><c> causation</c><00:02:26.920><c> of</c><00:02:27.280><c> the</c>

00:02:27.420 --> 00:02:27.430 align:start position:0%
the development and the causation of the
 

00:02:27.430 --> 00:02:31.350 align:start position:0%
the development and the causation of the
disease<00:02:27.820><c> we</c><00:02:28.570><c> went</c><00:02:29.410><c> on</c><00:02:29.530><c> to</c><00:02:29.770><c> show</c><00:02:30.040><c> which</c><00:02:30.460><c> immune</c>

00:02:31.350 --> 00:02:31.360 align:start position:0%
disease we went on to show which immune
 

00:02:31.360 --> 00:02:33.330 align:start position:0%
disease we went on to show which immune
pathways<00:02:31.630><c> might</c><00:02:32.200><c> be</c><00:02:32.380><c> important</c><00:02:32.860><c> in</c><00:02:33.010><c> the</c><00:02:33.130><c> cell</c>

00:02:33.330 --> 00:02:33.340 align:start position:0%
pathways might be important in the cell
 

00:02:33.340 --> 00:02:35.700 align:start position:0%
pathways might be important in the cell
death<00:02:33.610><c> of</c><00:02:33.850><c> the</c><00:02:33.940><c> hair</c><00:02:34.090><c> follicle</c><00:02:34.660><c> and</c><00:02:35.560><c> then</c>

00:02:35.700 --> 00:02:35.710 align:start position:0%
death of the hair follicle and then
 

00:02:35.710 --> 00:02:37.650 align:start position:0%
death of the hair follicle and then
using<00:02:36.100><c> those</c><00:02:36.220><c> insights</c><00:02:36.790><c> we</c><00:02:37.030><c> blocked</c><00:02:37.360><c> those</c>

00:02:37.650 --> 00:02:37.660 align:start position:0%
using those insights we blocked those
 

00:02:37.660 --> 00:02:41.160 align:start position:0%
using those insights we blocked those
pathways<00:02:38.410><c> in</c><00:02:39.010><c> the</c><00:02:39.250><c> mouse</c><00:02:39.430><c> models</c><00:02:39.990><c> showed</c><00:02:40.990><c> they</c>

00:02:41.160 --> 00:02:41.170 align:start position:0%
pathways in the mouse models showed they
 

00:02:41.170 --> 00:02:43.410 align:start position:0%
pathways in the mouse models showed they
were<00:02:41.200><c> efficacious</c><00:02:42.010><c> and</c><00:02:42.310><c> then</c><00:02:42.459><c> went</c><00:02:42.640><c> on</c><00:02:42.730><c> to</c><00:02:42.940><c> go</c>

00:02:43.410 --> 00:02:43.420 align:start position:0%
were efficacious and then went on to go
 

00:02:43.420 --> 00:02:47.160 align:start position:0%
were efficacious and then went on to go
on<00:02:43.630><c> to</c><00:02:44.020><c> try</c><00:02:44.770><c> medically</c><00:02:45.490><c> relevant</c><00:02:46.170><c> antibodies</c>

00:02:47.160 --> 00:02:47.170 align:start position:0%
on to try medically relevant antibodies
 

00:02:47.170 --> 00:02:49.920 align:start position:0%
on to try medically relevant antibodies
and<00:02:47.410><c> small</c><00:02:48.130><c> molecules</c><00:02:48.670><c> to</c><00:02:49.209><c> see</c><00:02:49.420><c> whether</c><00:02:49.660><c> when</c>

00:02:49.920 --> 00:02:49.930 align:start position:0%
and small molecules to see whether when
 

00:02:49.930 --> 00:02:51.840 align:start position:0%
and small molecules to see whether when
we<00:02:50.050><c> block</c><00:02:50.320><c> these</c><00:02:50.560><c> pathways</c><00:02:51.100><c> we</c><00:02:51.310><c> could</c><00:02:51.490><c> reverse</c>

00:02:51.840 --> 00:02:51.850 align:start position:0%
we block these pathways we could reverse
 

00:02:51.850 --> 00:02:53.820 align:start position:0%
we block these pathways we could reverse
the<00:02:52.060><c> alopecia</c><00:02:52.360><c> areata</c><00:02:52.720><c> and</c><00:02:53.350><c> we</c><00:02:53.560><c> showed</c><00:02:53.800><c> that</c>

00:02:53.820 --> 00:02:53.830 align:start position:0%
the alopecia areata and we showed that
 

00:02:53.830 --> 00:02:56.370 align:start position:0%
the alopecia areata and we showed that
it<00:02:54.160><c> was</c><00:02:54.190><c> true</c><00:02:54.550><c> in</c><00:02:54.820><c> mouse</c><00:02:55.540><c> models</c><00:02:56.050><c> and</c><00:02:56.260><c> then</c>

00:02:56.370 --> 00:02:56.380 align:start position:0%
it was true in mouse models and then
 

00:02:56.380 --> 00:02:59.220 align:start position:0%
it was true in mouse models and then
went<00:02:57.040><c> on</c><00:02:57.160><c> to</c><00:02:57.430><c> go</c><00:02:57.580><c> to</c><00:02:57.610><c> a</c><00:02:58.090><c> small</c><00:02:58.570><c> series</c><00:02:58.930><c> of</c>

00:02:59.220 --> 00:02:59.230 align:start position:0%
went on to go to a small series of
 

00:02:59.230 --> 00:03:00.690 align:start position:0%
went on to go to a small series of
patients<00:02:59.680><c> and</c><00:02:59.770><c> show</c><00:02:59.950><c> that</c><00:03:00.160><c> the</c><00:03:00.280><c> therapies</c>

00:03:00.690 --> 00:03:00.700 align:start position:0%
patients and show that the therapies
 

00:03:00.700 --> 00:03:03.270 align:start position:0%
patients and show that the therapies
could<00:03:00.880><c> also</c><00:03:01.090><c> be</c><00:03:01.360><c> effective</c><00:03:01.810><c> in</c><00:03:01.990><c> people</c><00:03:02.410><c> we</c><00:03:03.010><c> are</c>

00:03:03.270 --> 00:03:03.280 align:start position:0%
could also be effective in people we are
 

00:03:03.280 --> 00:03:06.720 align:start position:0%
could also be effective in people we are
very<00:03:03.520><c> committed</c><00:03:03.880><c> to</c><00:03:04.330><c> making</c><00:03:04.540><c> sure</c><00:03:04.810><c> that</c><00:03:05.730><c> that</c>

00:03:06.720 --> 00:03:06.730 align:start position:0%
very committed to making sure that that
 

00:03:06.730 --> 00:03:08.190 align:start position:0%
very committed to making sure that that
patients<00:03:07.209><c> with</c><00:03:07.360><c> alopecia</c><00:03:07.540><c> areata</c><00:03:07.930><c> have</c>

00:03:08.190 --> 00:03:08.200 align:start position:0%
patients with alopecia areata have
 

00:03:08.200 --> 00:03:10.980 align:start position:0%
patients with alopecia areata have
access<00:03:08.650><c> to</c><00:03:08.890><c> this</c><00:03:09.010><c> class</c><00:03:09.310><c> of</c><00:03:09.550><c> drugs</c><00:03:09.990><c> hopefully</c>

00:03:10.980 --> 00:03:10.990 align:start position:0%
access to this class of drugs hopefully
 

00:03:10.990 --> 00:03:12.600 align:start position:0%
access to this class of drugs hopefully
in<00:03:11.110><c> a</c><00:03:11.230><c> way</c><00:03:11.260><c> sauna</c><00:03:11.680><c> day</c><00:03:11.860><c> that's</c><00:03:12.100><c> not</c><00:03:12.220><c> an</c>

00:03:12.600 --> 00:03:12.610 align:start position:0%
in a way sauna day that's not an
 

00:03:12.610 --> 00:03:14.759 align:start position:0%
in a way sauna day that's not an
off-label<00:03:13.030><c> indication</c><00:03:13.810><c> meaning</c><00:03:14.350><c> we'd</c><00:03:14.560><c> like</c>

00:03:14.759 --> 00:03:14.769 align:start position:0%
off-label indication meaning we'd like
 

00:03:14.769 --> 00:03:17.520 align:start position:0%
off-label indication meaning we'd like
to<00:03:15.010><c> pursue</c><00:03:15.510><c> getting</c><00:03:16.510><c> a</c><00:03:16.810><c> label</c><00:03:17.140><c> getting</c><00:03:17.440><c> an</c>

00:03:17.520 --> 00:03:17.530 align:start position:0%
to pursue getting a label getting an
 

00:03:17.530 --> 00:03:19.710 align:start position:0%
to pursue getting a label getting an
indication<00:03:17.769><c> for</c><00:03:18.580><c> a</c><00:03:18.610><c> jak</c><00:03:19.060><c> inhibitor</c><00:03:19.540><c> in</c>

00:03:19.710 --> 00:03:19.720 align:start position:0%
indication for a jak inhibitor in
 

00:03:19.720 --> 00:03:22.320 align:start position:0%
indication for a jak inhibitor in
alopecia<00:03:20.110><c> areata</c><00:03:20.790><c> we're</c><00:03:21.790><c> deeply</c><00:03:22.150><c> committed</c>

00:03:22.320 --> 00:03:22.330 align:start position:0%
alopecia areata we're deeply committed
 

00:03:22.330 --> 00:03:23.970 align:start position:0%
alopecia areata we're deeply committed
to<00:03:22.720><c> doing</c><00:03:22.900><c> that</c><00:03:23.140><c> there</c><00:03:23.380><c> are</c><00:03:23.440><c> so</c><00:03:23.620><c> many</c><00:03:23.800><c> other</c>

00:03:23.970 --> 00:03:23.980 align:start position:0%
to doing that there are so many other
 

00:03:23.980 --> 00:03:27.000 align:start position:0%
to doing that there are so many other
diseases<00:03:24.400><c> if</c><00:03:24.880><c> you</c><00:03:25.000><c> will</c><00:03:25.150><c> ahead</c><00:03:25.450><c> of</c><00:03:25.570><c> us</c><00:03:26.010><c> other</c>

00:03:27.000 --> 00:03:27.010 align:start position:0%
diseases if you will ahead of us other
 

00:03:27.010 --> 00:03:28.860 align:start position:0%
diseases if you will ahead of us other
diseases<00:03:27.640><c> that</c><00:03:27.790><c> might</c><00:03:28.120><c> be</c><00:03:28.239><c> considered</c><00:03:28.600><c> much</c>

00:03:28.860 --> 00:03:28.870 align:start position:0%
diseases that might be considered much
 

00:03:28.870 --> 00:03:30.360 align:start position:0%
diseases that might be considered much
more<00:03:28.930><c> life-threatening</c><00:03:29.739><c> or</c><00:03:29.950><c> life-altering</c>

00:03:30.360 --> 00:03:30.370 align:start position:0%
more life-threatening or life-altering
 

00:03:30.370 --> 00:03:32.670 align:start position:0%
more life-threatening or life-altering
than<00:03:30.910><c> alopecia</c><00:03:31.209><c> can</c><00:03:31.720><c> sometimes</c><00:03:32.170><c> get</c><00:03:32.410><c> pushed</c>

00:03:32.670 --> 00:03:32.680 align:start position:0%
than alopecia can sometimes get pushed
 

00:03:32.680 --> 00:03:34.710 align:start position:0%
than alopecia can sometimes get pushed
to<00:03:33.280><c> the</c><00:03:33.400><c> backburner</c><00:03:33.580><c> or</c><00:03:34.090><c> to</c><00:03:34.239><c> the</c><00:03:34.360><c> bottom</c><00:03:34.510><c> of</c>

00:03:34.710 --> 00:03:34.720 align:start position:0%
to the backburner or to the bottom of
 

00:03:34.720 --> 00:03:36.630 align:start position:0%
to the backburner or to the bottom of
the<00:03:34.840><c> list</c><00:03:35.050><c> but</c><00:03:35.470><c> this</c><00:03:36.010><c> has</c><00:03:36.190><c> been</c><00:03:36.340><c> the</c><00:03:36.459><c> major</c>

00:03:36.630 --> 00:03:36.640 align:start position:0%
the list but this has been the major
 

00:03:36.640 --> 00:03:39.360 align:start position:0%
the list but this has been the major
focus<00:03:37.180><c> of</c><00:03:37.390><c> our</c><00:03:37.959><c> entire</c><00:03:38.290><c> group</c><00:03:38.680><c> and</c><00:03:38.980><c> we</c><00:03:39.190><c> would</c>

00:03:39.360 --> 00:03:39.370 align:start position:0%
focus of our entire group and we would
 

00:03:39.370 --> 00:03:40.979 align:start position:0%
focus of our entire group and we would
like<00:03:39.519><c> very</c><00:03:39.670><c> much</c><00:03:39.790><c> to</c><00:03:39.970><c> make</c><00:03:40.269><c> sure</c><00:03:40.450><c> that</c><00:03:40.690><c> this</c>

00:03:40.979 --> 00:03:40.989 align:start position:0%
like very much to make sure that this
 

00:03:40.989 --> 00:03:42.470 align:start position:0%
like very much to make sure that this
ball<00:03:41.200><c> gets</c><00:03:41.440><c> across</c><00:03:41.680><c> the</c><00:03:41.799><c> finish</c><00:03:42.100><c> line</c>

00:03:42.470 --> 00:03:42.480 align:start position:0%
ball gets across the finish line
 

00:03:42.480 --> 00:03:45.120 align:start position:0%
ball gets across the finish line
whatever<00:03:43.480><c> that</c><00:03:43.660><c> takes</c><00:03:43.870><c> and</c><00:03:44.230><c> hopefully</c><00:03:44.769><c> we'll</c>

00:03:45.120 --> 00:03:45.130 align:start position:0%
whatever that takes and hopefully we'll
 

00:03:45.130 --> 00:03:46.979 align:start position:0%
whatever that takes and hopefully we'll
be<00:03:45.310><c> joining</c><00:03:45.880><c> with</c><00:03:46.000><c> some</c><00:03:46.299><c> pharmaceutical</c>

00:03:46.979 --> 00:03:46.989 align:start position:0%
be joining with some pharmaceutical
 

00:03:46.989 --> 00:03:49.080 align:start position:0%
be joining with some pharmaceutical
partners<00:03:47.350><c> to</c><00:03:47.530><c> make</c><00:03:47.680><c> sure</c><00:03:47.739><c> that</c><00:03:48.730><c> alopecia</c>

00:03:49.080 --> 00:03:49.090 align:start position:0%
partners to make sure that alopecia
 

00:03:49.090 --> 00:03:51.390 align:start position:0%
partners to make sure that alopecia
stays<00:03:49.480><c> top</c><00:03:49.750><c> of</c><00:03:49.930><c> mind</c><00:03:50.140><c> and</c><00:03:50.769><c> that</c><00:03:50.950><c> someday</c><00:03:51.160><c> this</c>

00:03:51.390 --> 00:03:51.400 align:start position:0%
stays top of mind and that someday this
 

00:03:51.400 --> 00:03:53.160 align:start position:0%
stays top of mind and that someday this
is<00:03:51.580><c> an</c><00:03:51.730><c> approved</c><00:03:52.060><c> indication</c><00:03:52.660><c> for</c><00:03:52.959><c> jak</c>

00:03:53.160 --> 00:03:53.170 align:start position:0%
is an approved indication for jak
 

00:03:53.170 --> 00:03:55.560 align:start position:0%
is an approved indication for jak
inhibitor

